Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 18, 2018 16:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Present at Biotech Showcase 2019

HOUSTON, Dec. 18, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
November 09, 2018 06:50 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Reports Third Quarter 2018 Results

PLx has identified the alternate supply of a key ingredient for Vazalore HOUSTON, Nov. 09, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty...
November 01, 2018 07:00 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Discuss 2018 Third Quarter Financial Results on November 9, 2018 Conference Call

HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
September 10, 2018 16:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Present at Janney Healthcare Conference on September 18

HOUSTON, Sept. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
August 10, 2018 07:00 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Reports Second Quarter 2018 Results

HOUSTON, Aug. 10, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ: PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
June 11, 2018 16:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Present at JMP Securities Life Sciences Conference

HOUSTON, June 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
May 11, 2018 06:50 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Reports First Quarter 2018 Results

HOUSTON, May 11, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
March 23, 2018 06:50 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. Reports Fourth Quarter and Full Year 2017 Results

HOUSTON, March 23, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
March 15, 2018 16:30 ET | Source: PLx Pharma Inc.

PLx Pharma Inc. to Discuss 2017 Fourth Quarter and Full Year Financial Results on March 23, 2018 Conference Call

HOUSTON, March 15, 2018 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...
November 09, 2017 16:30 ET | Source: PLX Pharma Inc.

PLx Pharma Inc. Reports Third Quarter 2017 Results

HOUSTON, Nov. 09, 2017 (GLOBE NEWSWIRE) -- PLx Pharma Inc. (NASDAQ:PLXP) (“PLx” or the “Company”), a late-stage specialty pharmaceutical company focused on commercializing two patent-protected...